Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti‐Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists

Erin F. Barreto, Nathaniel J. Rhodes(Midwestern University), Andrea N. Edginton(University of Waterloo), Marc H. Scheetz(Midwestern University), Michael Neely(University of Southern California), Jason A. Roberts(Université de Montpellier), Sonya Tang Girdwood(Cincinnati Children's Hospital Medical Center), Lisa Hong(Loma Linda University), Andrés F. Zuluaga(Universidad de Antioquia), Rekha Pai Mangalore(Alfred Health), Rebecca Arriola(Midwestern University), Charles A. Peloquin(University of Florida), Erin K. McCreary(University of Pittsburgh), Angela Huttner(University Hospital of Geneva), Paul R. Yarnold(Optimal Solutions (United States)), Audrey N. Schuetz(Mayo Clinic), Gauri G. Rao(University of Southern California), Nicole Maranchick(American Association of Colleges of Pharmacy), Anka C. Röhr(Heidenhain (Germany)), Robert A. Bonomo(Louis Stokes Cleveland VA Medical Center), Cynthia Bens(Long Term Care Community Coalition), Birgit C. P. Koch(University Medical Center Groningen)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
July 22, 2026
Cited by 0


Related Papers